{
  "docId": "019de072-65f6-7273-bf5f-9dfce8e99600",
  "docSlug": "b41af86b98765dd2459355c3b31d267e",
  "documentTitle": "OmniAb | SPAC Presentation Deck | 35 slides",
  "authorId": "omniab",
  "authorName": "OmniAb",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 35,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a split-layout to contrast the specific asset (OmniAb) with the broader investment firm (Avista Capital Partners) and its portfolio companies.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de072-65f6-7273-bf5f-9dfce8e99600/5",
  "deckHref": "/decks/019de072-65f6-7273-bf5f-9dfce8e99600",
  "deckJsonHref": "/decks/019de072-65f6-7273-bf5f-9dfce8e99600.json",
  "deckAnchorHref": "/decks/019de072-65f6-7273-bf5f-9dfce8e99600#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.6,
        "x": 0.36,
        "y": 0.35
      },
      "kind": "image",
      "text": "BioReliance, Charles River, eMolecules, INC Research, Syneos Health, UBC, FOCUS Diagnostics, MPI Research",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e07cbc13-8704-4ea7-8f8d-3c789a471d55",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.58,
        "x": 0.37,
        "y": 0.6
      },
      "kind": "list",
      "text": "Avista investment professionals have deep domain expertise... Eight completed investments... Track record of creating value through: Investing to add new capabilities, Margin expansion, Accretive M&A, Creative financings",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d548e77-61a0-4274-8560-2f0716bae70a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.07,
        "y": 0.6
      },
      "kind": "list",
      "text": "Built capabilities and competitive strengths to become partner of choice: BI designed to yield industry's most diverse sets of high-quality antibodies, Rapid deep sequencing of immune repertoires, Differentiated ion channel capabilities, Diversified business model, Robust IP portfolio",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e438f46f-12e8-4d3a-8419-5389d3f77e7b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "ADDING A LEADING DRUG DISCOVERY PLATFORM TO AVISTA'S PHARMA SERVICES PORTFOLIO",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "30ec6932-a9b3-49a2-bdb9-669947668257",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "657e9a6c-f7b1-41ea-8791-c765d49f075d",
      "evidence": "Built capabilities and competitive strengths to become partner of choice",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}